OXiGENE Inc (NASDAQ:OXGN), a biopharmaceutical company developing novel therapies for treatment of cancer, today reported financial results for the quarter ended June 30, 2015. …
OXiGENE Inc (NASDAQ:OXGN), a biopharmaceutical company developing novel therapies for treatment of cancer, announced that Matthew M. Loar has been appointed Chief Financial Officer.
H.C.
MLV’s healthcare analyst Thomas Yip weighed in today with a few insights on OXiGENE Inc (NASDAQ:OXGN), after the company announced the basic design of an upcoming …
OXiGENE Inc (NASDAQ:OXGN), a biopharmaceutical company developing novel therapies for the treatment of cancer, provided an update on recent discussions with the U.S.
OXiGENE Inc (NASDAQ:OXGN), a biopharmaceutical company developing novel therapies for the treatment of cancer, today announced that the U.S.
OXiGENE Inc (NASDAQ:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, today announced the appointment of a new President and Chief Executive …
MLV analyst Thomas Yip came out with his views on OXiGENE Inc (NASDAQ:OXGN), after the company reported its first-quarter results and hosted a call to discuss the latest progress …
OXiGENE Inc (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, announced that it has entered into definitive agreements with institutional investors …
